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INTRODUCTION
Two of the maternity care quality indicators are
maternal and perinatal mortality. Approximately
600,000 women die from pregnancy-related
disorders annually, and 98% of the deaths occurs
in the developing countries. The Maternal
Mortality Rate (MMR) in Indonesia is still far from
the Millennium Development Goals (MDGs) target.
The 2015 MMR target was 102 per 100,000 live
births, while the infant mortality rate (IMR) target
was 23 per 1.000 live births.1-4
Preeclampsia is a pregnancy specific condition
characterized by placental and maternal response
dysfunction to systemic inflammation, accompanied
with endothelial activation and coagulation.
Preeclampsia is a major cause of morbidity and
mortality of pregnant women and newborns,
occurred in approximately 2-8% of all pregnancies
in the world. The majority of preeclampsia onset
is late (> 34 weeks), and 10% is early (< 34
weeks).5-7
Several risk factors for preeclampsia include
primigravida, hyperplacentosis, aged < 20 years or
> 35 years, previous history of preeclampsia/
eclampsia, obesity, multiple pregnancies, medical
abnormal history due to endothelial dysfunction
such as chronic hypertension, and pregestational
diabetes mellitus.5,7,8
Abstract
Objective: To determine the ratio of serum endothelin-1 levels
between severe preeclampsia and normotensive pregnancy.
Methods: Observational analytic study using cross-sectional. Six-
teen woman with normal pregnancy and sixteen others with severe
preeclampsia who met the inclusion and exclusion criteria, were
tested for ET-1. The serum was analyzed at Prodia Laboratory,
Manado. The ET-1 level was examined using ELISA (R&D Systems,
Inc., Minneapolis, MN 55413, USA). The data obtained was analyzed
using SPSS software version 20.0.and discussions were held using
the existing literature theory.
Results: The mean and median levels of endothelin-1 plasma in
patients with severe preeclampsia is 2:46  1:44 pg/ml, 1:09  0:26
pg/ml, whereas in normotensive pregnancy is 1:03  0:26 pg/ml,
1.95  1:44 pg/ml with p < 0:05 (0000).
Conclusion: There was a significant difference between endo-
thelin-1 level in severe preeclampsia and normotensive preg-
nancies.
[Indones J Obstet Gynecol 2017; 5-2: 77-82]
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Abstrak
Tujuan: Mengetahui perbandingan kadar endothelin-1 antara
kehamilan preeklamsia berat dan kehamilan normotensi.
Metode: Penelitian kuantitatif observasional analitik menggunakan
pendekatan potong lintang. Dilakukan pemeriksaan kadar endo-thelin-1 pada 32 sampel ibu hamil yang memenuhi kriteria inklusi dan
eksklusi, terdiri atas 16 kehamilan preeklamsia berat dan 16 keha-
milan normotensi. Analisis sampel dilakukan di Laboratorium ProdiaManado. Pemeriksaan kadar endothelin-1 menggunakan metode
ELISA. Data yang diperoleh diolah dengan menggunakan perangkatlunak SPSS versi 20.0 dan dilakukan pembahasan menggunakan
teori kepustakaan yang ada.
Hasil: Rerata dan median kadar endothelin-1 plasma pada pen-
derita preeklamsia berat yaitu 2,46  1,44 pg/ml, 1,09  0,6 pg/ml,
sedangkan pada kehamilan normotensi yaitu 1,03  0,26 pg/ml, 1,95
 1,44 pg/ml dengan nilai p < 0,05 (0,000).
Kesimpulan: Terdapat perbedaan signifikan kadar endothelin-1
antara kehamilan preeklamsia berat dengan kehamilan normotensi.
[Maj Obstet Ginekol Indones 2017; 5-2: 77-82]
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Preeclampsia is usually started by a decrease in
utero-placental perfusion due to a cytotrophoblast
abnormal invasion in uterine spiral arteries. A
placental hypoxia will cause a decrease in placental
perfusion. In such circumstances, an imbalance
between pro-angiogenic and antiangiogenic factors
occur. There are two antiangiogenic proteins pro-
duced excessively in preeclamptic patients, which
include soluble Fms-like tyrosine kinase-1 (sFlt-1)
and soluble endoglin where ET-1 as a mediator of
hypertension. Due to increased free radical and
cytokine, decreased proangiogenic factors (VEGF
and PIGF), and uncontrolled increase in lipid
peroxide, vascular endothelial dysfunction
occurs.9,10
ET-1 is a potent vasoconstrictor produced by
endothelial cells, macrophages, fibroblasts, and
cardiac myocytes. It is a family of peptide
composed of 21 amino acids with two intra-
molecular disulfide bonds. Increased ET-1 level
plays an important role in the development of
hypertension in pregnancy, which may later
progress to preeclampsia.6,11,12 Several studies
suggested that preeclamptic subjects with higher
ET-1 levels had poorer prognosis. We aimed to
compare ET-1 serum levels between severe
preeclampsia and normotensive pregnancy.
METHODS
We conducted a cross-sectional study to compare
the ET-1 serum in severe preeclampsia and nor-
motensive pregnancies. This study was conducted
at the Obstetrics and Gynecology Department of
the Prof. dr. R. D. Kandou Hospital, Manado, and
the sister teaching hospitals in Manado, during the
period of October 2015 to November 2015.
The study population were all pregnancy out-
patients with severe preeclampsia and those with
normal blood pressure at the hospitals. The
inclusion criteria were pregnant women with
gestational age above 20 weeks, diagnosed with
severe preeclampsia and were willing to partici-
pate in research. The exclusion criteria were
pregnant women with chronic illnesses: diabetes
mellitus, chronic hypertension, renal disease,
thyroid disease, and patients who had received
the cholesterol medication, twin pregnancies, and
those who refused to participate in the study.
The control group was the normotensive pregnant
women with the same gestational age. We collected
the sample by consecutive sampling, where every
patient who met the study criteria would be
included in the study until the minimum number
of samples met. Statistical analyses were
conducted using SPSS. T test was used for
numerical variables.
RESULTS
The total number of subjects was 32, consisted of
16 normotensive pregnant women and 16 severe
preeclamptic women. Demographic characteristics
of the subjects are presented in Table 1.
Tabel 1. Demographic Characteristics of the Subjects
Characteristics
Normal pregnancy Severe preeclampsia
n % n %
Mother age
< 35 years old 14 88 8 50
 35 years old 2 12 8 50
Parity
Primigravida 8 50 6 38
Multigravida 8 50 10 62
Gestational age
Preterm 5 31 6 38
Aterm 11 69 10 62
Education
Primary school 0 0 1 7
Junior high 3 19 3 19
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We found no significant difference between the
preeclamptic population and the normotensive group
(p > 0.05) for the following variables: maternal
age, parity, AST, the number of hemoglobin and
platelets, BMI and birth weight. There were
significant differences between the preeclamptic
and normotensive groups for these variables:
systolic, diastolic and the levels of ALT (p < 0.05).
From Graph 1, the obtained results mean and
median distribution of ET-1 appears to be higher
severe preeclampsia (2.46  1.44 pg/ml, 1.95 
1.44 pg/ml) compared to normotensive pregnancy
(1.03  0.26 pg/ml, 1.09  0.26 pg/ml). This result
demonstrate increased levels of ET-1 in severe
preeclampsia compared to normotensive preg-
nancy.
Characteristics
Normal pregnancy Severe preeclampsia
n % n %
High school 13 81 10 62
Diploma 0 0 0 0
Graduate 0 0 2 12
Occupation
Public servant 1 6 2 13
Private employee 0 0 0 0
Student 2 13 1 6
Housewife 13 81 13 81
History of Preeclampsia
Negative 16 100 13 81
Positive 0 0 3 19
Body Mass Index
 25 12 75 10 62
> 25 4 25 6 38
Infant Birth weight
 2500 3 19 6 38
> 2500 13 81 10 62
Table 2. Comparison of the Characteristics between Subjects with Preeclampsia and Normal Pregnancy
Variables
Normal pregnancy Severe preeclampsia
p
Mean Median SD Mean Median SD
Age 26.19 27.5 7.26 30.88 34.5 6.95 0.51
Parity 1.75 1.5 1.54 3 2.5 2.03 0.16
Systole 112.5 110 7.75 168.13 160 21.67 0
Diastole 73.13 70 4.79 113.13 110 15.37 0
AST 21 19 6.55 36.44 28.5 31.46 0.138
ALT 12 11.5 3.5 24.81 19.5 21.69 0.043
Hemoglobin 11.41 11.1 1.47 10.66 11.65 3.95 0.669
Platelet 284125 266000 60202 294688 294500 78408 0.672
BMI 22.94 21.5 5.29 24.25 23.5 4.09 0.196
Birth weight 2806.25 3050 831.44 2653.13 2750 642.77 0.16
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The Mann-Whitney statistical test showed that
there were significant differences between the
levels of endothelin-1 between the severe
preeclamptic and the normotensive groups (p =
0.000). This means that the concentration of
endothelin-1 affects the occurence of severe
preeclampsia.
DISCUSSION
Approximately 5-10% of pregnant women
experienced a syndrome known as preeclampsia.
In women with normotensive pregnancies, a
thorough physiological alterations and body
system adaptation occur. In cardiovascular system,
ET-1 receptor blockage maintains the vascular
tone. Pregnant women with risk factors, such as
maternal disease and oxidative stress, the
angiogenic factor were dysfunctional.14
Multiple evidence suggested that ET-1 was one
of the preeclampsia pathophysiological factors.
When the preeclampsia and the normotensive
groups were compared, an elevated ET-1 in
preeclampsia group was found. It indicates that the
concentration of ET-1 affects the occurrence of
severe preeclampsia.11
Early incident in preeclampsia occurs due to
decreased utero-placental perfusion, which
happens because of remodelling failure of the
spiral arteries and endothelial dysfunction.
Placental hypoxia will lead to decreased placental
perfusion. In such circumstane, an imbalance
factors between proangiogenic and antiangiogenic
occurs. In preeclampsia, there are two antiangio-
genic proteins produced excessively in the
maternal circulation: soluble Fms-like tyrosine
kinase-1 (sFlt-1) and soluble endoglin where
ET-1 as a mediator of hypertension. Due to
increase in free radical and cytokine causing
oxidative stress and decrease in proangiogenic
factors VEGF, PIGF and an uncontrolled increase in
lipid peroxide. This causes vascular endothelial
dysfunction that is disintegration of endothelial
structure and function.9,10
Increase in endothelin-1 in the circulation of
pregnant women have an important role in the
occurrence of hypertension in pregnancy and may
develop into preeclampsia. In several different
studies, preeclamptic patients with higher ET-1
level in the maternal circulation had poorer
prognosis.11,15
The obtained results mean and median distri-
bution of ET-1 appears to be higher in severe
preeclampsia compared with normotensive
pregnancies. The interpretation result indicates
that the presence of increased levels of ET-1 in
severe preeclampsia compare with normotensive
pregnancies. This means that the concentration of
endothelin-1 affects the occurence of severe
preeclampsia.
Croom et al conducted are search on the serum
level of ET-1 in normal pregnancy and preeclamp-
sia. This study demonstrated increased levels of
ET-1 in preeclampsia compared to normal preg-
nancy. In normal pregnancy, the level of ET-1 0.5
pg/ml (1st trimester), 1.1 pg/ml (3rd trimester),
and 1.7 pg/ml (at birth). Whereas in patients with
preeclampsia, level of ET-1 1.9 pg/ml (before de-
livery) and 3.5 pg/ml (at birth). Slowinski et al
found a very strong relationship between the level
of ET-1 in patients and preeclampsia at 24 weeks
and 36 weeks of pregnancy compared to normo-
tensive pregnancy. The level of ET-1 was higher in
preeclamptic patients at both gestational ages
(1.07  2.00 vs 0.54  0.56 pg/ml, p=0.045 at 24
weeks and 0.75  1.20 vs 0.44  0.45 pg/ml,
p=0.023 at 36 weeks).16,17
Several studies have shown that ET-1 is asso-
ciated with the development of preeclampsia. The
levels of ET-1 in preeclamptic patients increased
significantly compared to normal pregnancy. ET-1
Figure 1. The ET-1 Correlation between Severe
Preeclampsia and Normotensive Pregnancy
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is a potent vasoconstrictor that can be used as
predictors of hypertension and preeclampsia.
Increase in ET-1 indicated vasospasm progressivity
accompanied with decreased renal plasma flow
and utero-placental blood flow. Finally, elevated
ET-1 level is responsible formitogenic activity
reported on preeclampsia.6,13
Aggarwal et al found that ET-1 level in
preeclampsia was higher compared to normo-
tensive pregnancy (1.52  0.55 vs 0.88  0.35
pg/ml, p<0.001). Nova et al found that ET-1 was
highest in patients with HELLP syndrome than
without HELLP syndrome and the lowest in
normotensive group.13,18
Kamoi et al suggested that ET-1 level in nor-
motensive pregnant women was lower than non
pregnant women (0.6  0.1 vs 1.5  0.3pg/ml) and
higher in women with pregnancy-induced hyper-
tension (1.9  0.3 pg/ml). After delivery, increased
levels of ET-1 would go back to its normal level in
line with decreased blood pressure in all patients.
Meanwhile, in pregnant women with chronic
hypertension, the ET-1 levels were slightly higher
compared to normotensive pregnant women (0.9
 0.3 pg/ml, p<0.01). In a study of 6 patients with
pregnancy induced hypertension (PIH), 2 patients
with pregnancy induced proteinuria (PIP) without
hypertension and 7 normotensive pregnant women
which was conducted by Ohya et al, subjects with
PIP had the highest levels of ET-1, while the
normotensive pregnant population had the lowest
levels (4.4  0.5 vs 4.5  0.6 vs 1.5  0.2 pg/ml).
One week after delivery, ET-1 level in PIH and PIP
were still high. After one month, the level of ET-1
in PIH population began to decline, whereas the
PIP population still had high ET-1 levels.19,20
In the severe preeclamptic group, four subjects
had complications, in which two subjects deve-
loped suffered from eclampsia, one subject had
eclampsia and one subject suffered from eclampsia
with HELLP syndrome. Of these subjects, four them
had their ET-1 levels increased significantly, which
may indicate further endothelial damage in
preeclampsia. These findings are consistent with a
study conducted by Nova et al, which found that
ET-1 level were significantly elevated in patients
with HELLP syndrome compared without HELLP
syndrome. However, this needs to be done with
greater samples to assess the association between
complications of preeclampsia with high levels of
ET-1.13
This study has some limitations that may affect
the results. Counfounding factors including level of
urea, creatinine and other biochemical mediators
as predispositions of preeclampsia, were not
controlled. In addition, we did not examine other
biochemical factors that were expected to influence
ET-1 levels to our subjects. Family physicians and
maternity care provider should educate patient
and families to do antenatal care regularly to detect
high risk pregnancies, including the early signs of
preeclampsia, therefore prevention and treatment
can be done as early as possible and is expected to
reduce maternal and perinatal morbidity and
mortality. Further studies with larger sample size
are required to obtain the causal association
between ET-1 and the complications of
preeclampsia.
REFERENCES
1. Angsar MD. Hipertensi dalam Kehamilan pada Ilmu
Kebidanan Sarwono Prawiroharjo. 4 ed. Jakarta: PT Bina
Pustaka Sarwono Prawirohardjo; 2010: 530-61.
2. World Health Organization. Maternal Mortality in 2005:
Estimates Developed by WHO, UNICEF, UNFPA and The
World Bank. Geneve: World Health Organization, 2007.
3. Badan Kependudukan dan Keluarga Berencana Nasional.
Survei Demografi dan Kesehatan Indonesia 2012. Jakarta:
Badan Pusat Statistik; 2013: 110-2, 226-8.
4. Supriyantoro, Primadi O. Profil Kesehatan Indonesia Tahun
2013. Jakarta: Kementerian Kesehatan Republik Indonesia;
2014: 71-83.
5. Wibowo N, Irwinda R, Frisdiantiny E. Pedoman Nasional
Pelayanan Kedokteran: Diagnosis dan Tatalaksana Pre-
eklamsia: Kementerian Kesehatan Republik Indonesia; 2014.
6. Jain A. Endothelin-1: A Key Pathological Factor in Pree-
clampsia? Reprod Bio Med Online. 2012; 25: 443-9.
7. Roeshadi RH. Hipertensi dalam Kehamilan In: Hariadi R,
editor. Ilmu Kedokteran Fetomaternal. 1st ed. Surabaya:
Himpunan Kedokteran Fetomaternal POGI; 2004: 494-8.
8. Moffett A and Hiby SE. Immunological Factors and Placen-
tation: Implications for Pre-eclampsia in Preeclampsia:
Etiology and Clinical Practice. Lyall F and Belfort M. New
York: Cambridge University Press. 2007: 92-102.
9. Maynard SE, Karumanchi SA. Angiogenic Factors and Pree-
clampsia. Semin Nephrol. 2011; 31(1): 33-46.
10. Karumanchi SA and Cerdeira AS. Angiogenic Factors in
Preeclampsia and Related Disorders. Cold Spring Harb
Perspect Med. 2012: 1-17.
11. George EM, Granger JP. Endothelin: Key Mediator of
Hypertension in Preeclampsia. Am J Hypertens. 2011;
24(9): 964-9.
12. Dhaun N, Goddard J, Kohan DE, Pollock DM, Schiffrin EL,
Webb DJ. Role of Endothelin-1 in Clinical Hypertension: 20
Years On. Am J Hypertens. 2008; 52: 452-9.
13. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD.
Maternal Plasma Level of Endothelin is Increased in
Preeclampsia. Am J Obstet Gynecol. 1991; 165(3): 724-7.
Vol 5, No 2
April 2017 Endothelin-1 levels in pregnant women  81
14. Cunningham FG, Hauth JC, Rouse DC, Spong CY. Pregnancy
Hypertension. Williams Obstetrics. 23th ed. New York:
McGraw Hill; 2010: 567-618.
15. Noori M, Savvidou M and Williams D. Endothelial Factors
in Preeclampsia: Etiology and Clinical Practice. Lyall F and
Belfort M. New York: Cambridge University Press. 2007:
50-77.
16. Slowinski T, Neumayer H, Stolze T, Gossing G, Halle H, and
Hocher B. Endothelin System in Normal and Hypertensive
Pregnancy. Clin Science. 2002; 103: 4465-95.
17. Croom C, Nolan T, Devoe L, Lightfoot B, and Caruana R. En-
dothelin-1 Serum Levels in Normal and Preeclamptic Preg-
nancies. Am J Obstet Gynecol. 1992; 161(1 part 2): 440.
18. Anggarwal PK, Chandel N, Jain V and Jha V. The Relationship
between Circulating Endothelin-1, Soluble Fims-like
Tyrosine Kinase-1 and Soluble Endoglin in Preeclampsia.
J Hum Hipertense. 2012; 26: 236-41.
19. Kamoi K, Sudo N, Ishibashi M, and Yamaji T. Plasma
Endothelin-1 Level in Patients with Pregnancy-Induced
Hypertension. N Engl J Med. 1990; 323: 1486-7.
20. Ohya Y, Nagafuchi E, Kumamoto K, Nakao Y, Fujita S, and
Fuhishima M. Endothelin-1 Levels during Pregnancy and
Postpartum in Normal pregnancy and Pregnancy-Induced
Hypertension. Hypertens Res. 1992; 15: 149-54.
Indones J
82  Wijaya et al Obstet Gynecol
